MedTrace Logo

Paracetamol With or Without Ketoprofen in the Management of Pain for Patients Receiving Brachytherapy (KETOCOL-1304)

NCT02439034 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2026-03-16

No results posted yet for this study

Summary

The results of the study will permit to set up a standardized and validated procedure of pain management authorizing medical and paramedical staff of brachytherapy department to handle pain and in this way to improve the quality of life of the patients.

Conditions

  • Uterine Cervical Cancer
  • Upper Aerodigestive Tract Neoplasms

Interventions

DRUG

Paracetamol

Paracetamol 1 g IV then 1 g 3 times a day IV or oral (PO)

DRUG

Ketoprofen

Ketoprofen\* 100 mg (IV then PO) : Ketoprofen 100 mg IV 2 times a day or Ketoprofen LP 100 mg PO 2 times a day.

Sponsors & Collaborators

  • Santelys Association

    collaborator OTHER

  • Centre Oscar Lambret

    lead OTHER

Principal Investigators

  • Danièle LEFEBVRE-KUNTZ, MD · Centre Oscar Lambret

  • Nathalie LEROUX, MD · Centre Oscar Lambret

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2016-09-30
Completion
2016-10-31

Countries

  • France

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02439034 on ClinicalTrials.gov